The lectin‐like domain of thrombomodulin is a drug candidate for both prophylaxis and treatment of liver ischemia and reperfusion injury in mice

[1]  Y. Otomo,et al.  Human Soluble Recombinant Thrombomodulin, ART-123, Resolved Early Phase Coagulopathies, but Did Not Significantly Alter the 28 Day Outcome in the Treatment of DIC Associated with Infectious Systemic Inflammatory Response Syndromes , 2019, Journal of clinical medicine.

[2]  S. Uemoto,et al.  Up-regulation of FOXO1 and reduced inflammation by β-hydroxybutyric acid are essential diet restriction benefits against liver injury , 2019, Proceedings of the National Academy of Sciences.

[3]  M. Murphy,et al.  The damage-associated molecular pattern HMGB1 is released early after clinical hepatic ischemia/reperfusion. , 2019, Biochimica et biophysica acta. Molecular basis of disease.

[4]  Min Zhang,et al.  Damage‐Associated Molecular Patterns Induce Inflammatory Injury During Machine Preservation of the Liver: Potential Targets to Enhance a Promising Technology , 2019, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[5]  R. Alon,et al.  Distinct Compartmentalization of the Chemokines CXCL1 and CXCL2 and the Atypical Receptor ACKR1 Determine Discrete Stages of Neutrophil Diapedesis , 2018, Immunity.

[6]  E. Conway,et al.  Exploring traditional and nontraditional roles for thrombomodulin. , 2018, Blood.

[7]  S. Uemoto,et al.  Preventive Effect of Antioxidative Nutrient-Rich Enteral Diet Against Liver Ischemia and Reperfusion Injury. , 2018, JPEN. Journal of parenteral and enteral nutrition.

[8]  Y. Maehara,et al.  Potential effect of recombinant thrombomodulin on ischemia–reperfusion liver injury in rats , 2018, Hepatology research : the official journal of the Japan Society of Hepatology.

[9]  W. Yao,et al.  Propofol post‐conditioning alleviates hepatic ischaemia reperfusion injury via BRG1‐mediated Nrf2/HO‐1 transcriptional activation in human and mice , 2017, Journal of cellular and molecular medicine.

[10]  S. Uemoto,et al.  Thrombomodulin Attenuates Inflammatory Damage Due to Liver Ischemia and Reperfusion Injury in Mice in Toll‐Like Receptor 4–Dependent Manner , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[11]  N. Ohuchi,et al.  Soluble Thrombomodulin Ameliorates Ischemia-Reperfusion Injury of Liver Grafts by Modulating the Proinflammatory Role of High-Mobility Group Box 1. , 2016, The Tohoku journal of experimental medicine.

[12]  E. Conway,et al.  The lectin like domain of thrombomodulin is involved in the defence against pyelonephritis. , 2015, Thrombosis research.

[13]  L. Marti,et al.  Chemokines and immunity , 2015, Einstein.

[14]  T. Niki,et al.  The protective function of galectin‐9 in liver ischemia and reperfusion injury in mice , 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[15]  L. Toledo-Pereyra,et al.  Molecular responses to ischemia and reperfusion in the liver , 2015, Archives of Toxicology.

[16]  T. Ikezoe.  Thrombomodulin/activated protein C system in septic disseminated intravascular coagulation , 2015, Journal of Intensive Care.

[17]  N. Kuriyama,et al.  Thrombomodulin administration attenuates ischemia-reperfusion injury of the remnant liver after 70% hepatectomy in rats: simulated model of small-for-size graft in living donor liver transplantation. , 2014, Transplantation proceedings.

[18]  J. Stypmann,et al.  Thrombomodulin's lectin-like domain reduces myocardial damage by interfering with HMGB1-mediated TLR2 signalling. , 2014, Cardiovascular research.

[19]  D. Stolz,et al.  Cellular‐specific role of toll‐like receptor 4 in hepatic ischemia‐reperfusion injury in mice , 2013, Hepatology.

[20]  Hua-Lin Wu,et al.  The role of thrombomodulin lectin-like domain in inflammation , 2012, Journal of Biomedical Science.

[21]  S. Miyagi,et al.  Recombinant human soluble thrombomodulin (ART-123) prevents warm ischemia-reperfusion injury in liver grafts from non-heart-beating donors. , 2012, Transplantation proceedings.

[22]  B. Ke,et al.  T-cell immunoglobulin mucin-3 determines severity of liver ischemia/reperfusion injury in mice in a TLR4-dependent manner. , 2010, Gastroenterology.

[23]  R. Busuttil,et al.  The Protective Function of Neutrophil Elastase Inhibitor in Liver Ischemia/Reperfusion Injury , 2010, Transplantation.

[24]  B. Ke,et al.  The emerging role of T cell immunoglobulin mucin‐1 in the mechanism of liver ischemia and reperfusion injury in the mouse , 2010, Hepatology.

[25]  R. Busuttil,et al.  The inhibition of neutrophil elastase ameliorates mouse liver damage due to ischemia and reperfusion , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[26]  B. Molitoris,et al.  Soluble thrombomodulin protects ischemic kidneys. , 2009, Journal of the American Society of Nephrology : JASN.

[27]  Chi‐Huey Wong,et al.  Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response. , 2008, Blood.

[28]  G. Verleden,et al.  The lectin-like domain of thrombomodulin protects against ischaemia–reperfusion lung injury , 2008 .

[29]  Hiroshi Yamamoto,et al.  The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. , 2005, The Journal of clinical investigation.

[30]  K. Tracey,et al.  The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion , 2005, The Journal of experimental medicine.

[31]  J. Takamatsu,et al.  A Comparative Double-Blind Randomized Trial of Activated Protein C and Unfractionated Heparin in the Treatment of Disseminated Intravascular Coagulation , 2002, International journal of hematology.

[32]  S Gelman,et al.  Pathophysiology, Clinical Manifestations, and Prevention of Ischemia-Reperfusion Injury , 2001, Anesthesiology.

[33]  R. Busuttil,et al.  Current status of ischemia and reperfusion injury in the liver , 2000 .

[34]  Robert Huber,et al.  Structural basis for the anticoagulant activity of the thrombin–thrombomodulin complex , 2000, Nature.

[35]  R. Bentley,et al.  Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. , 1999, Transplantation.

[36]  Edwards,et al.  Chemokine involvement in hepatic ischemia/reperfusion injury in mice: Roles for macrophage inflammatory protein‐2 and KC , 1998, Hepatology.

[37]  A. Lentsch,et al.  Chemokine involvement in hepatic ischemia/reperfusion injury in mice: Roles for macrophage inflammatory protein‐2 and kupffer cells , 1998, Hepatology.

[38]  C. Esmon,et al.  The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[39]  L. Toledo-Pereyra,et al.  NEUTROPHIL INFILTRATION AS AN IMPORTANT FACTOR IN LIVER ISCHEMIA AND REPERFUSION INJURY , 1993, Transplantation.

[40]  J. McCord,et al.  Oxygen-derived free radicals in postischemic tissue injury. , 1985, The New England journal of medicine.

[41]  E. Conway.  Thrombomodulin and its role in inflammation , 2011, Seminars in Immunopathology.

[42]  A. Malik,et al.  Toll-like receptor-4 (TLR4) signaling augments chemokine-induced neutrophil migration by modulating cell surface expression of chemokine receptors , 2003, Nature Medicine.

[43]  H. Rüdiger,et al.  Tumor necrosis factor alpha, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver. , 2002, Gastroenterology.

[44]  R. Bentley,et al.  Calpain mediates ischemic injury of the liver through modulation of apoptosis and necrosis. , 1999, Gastroenterology.